Table 5. Diagnostic accuracy of noncancerous and cancerous lesions in the US group and CEUS group.
| Final diagnosis | Diagnostic accuracy of biopsy, n (%) | P value | |
|---|---|---|---|
| US group | CEUS group | ||
| Non-carcinoma | 38/46 (82.6%) | 14/15 (93.3%) | 0.430 |
| Lymphoma | 17/21 (81.0%) | 9/10 (90.0%) | 0.472 |
| Thymic tumor | 14/17 (82.4%) | 3/3 (100%) | 0.596 |
| Germ cell tumor | 7/8 (87.5%) | 2/2 (100%) | 0.800 |
| Carcinoma* | 0/2 (0%) | 5/5 (100%) | 0.048 |
| Total | 38/48 (79.2%) | 19/20 (95.0%) | 0.210 |
*, included 1 lung adenocarcinoma; 1 lung squamous cell carcinoma; 2 neuroendocrine carcinomas; 1 esophageal squamous cell carcinoma; 1 metastasis of rectal carcinoma; 1 metastasis of lung squamous cell carcinoma. US, ultrasound; CEUS, contrast enhanced ultrasound.